Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases
- 1 January 2012
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 25 (1), 75-85
- https://doi.org/10.1038/modpathol.2011.134
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapyHistopathology, 2011
- Consistent MYC and FLT4 gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesionsGenes, Chromosomes and Cancer, 2010
- MYC High Level Gene Amplification Is a Distinctive Feature of Angiosarcomas after Irradiation or Chronic LymphedemaThe American Journal of Pathology, 2010
- Prognostic significance of c-Myc expression in soft tissue leiomyosarcomaLaboratory Investigation, 2009
- Modelling Myc inhibition as a cancer therapyNature, 2008
- Radiogenic Lymphangiogenesis in the SkinThe American Journal of Pathology, 2007
- MYC Amplification and Polysomy 8 in Chondrosarcoma: Array Comparative Genomic Hybridization, Fluorescent In Situ Hybridization, and Association With OutcomeJournal of Clinical Oncology, 2005
- Postradiation vascular proliferations: an increasing problemHistopathology, 2005
- Molecular cytogenetic characterization of proximal‐type epithelioid sarcomaGenes, Chromosomes and Cancer, 2004
- Benign lymphangiomatous papules of the skin following radiotherapy: a report of five new cases and review of the literatureHistopathology, 1999